China Anti-Cancer Association (CACA) is a non-governmental and non-profit organization in the field of oncology in China. Founded in 1984, it has developed into the largest organization in cancer field with long history and great influence in China. Up to now, CACA has established local anti-cancer associations in all 31 provinces, cities, and autonomous regions across China, creating a network of 200 professional societies. With 162 organization members and over 800,000 individual members, CACA serves as a significant platform for academic exchanges, public education, promoting CACA Guidelines, and international cooperation in the field of oncology.
Cheeky Charity
Cheeky Charity reduces colorectal and anal cancer disparities in LGBTQ+ communities through culturally competent advocacy. Our Butts & Badges program equips healthcare providers at 90+ clinics with 9,000 staff participants to initiate screening conversations with underserved populations. We partner with 100+ organizations, conducting research-informed education to advance health equity nationwide.
American Brain Tumor Association (ABTA)
For more than 50 years, the American Brain Tumor Association has been providing comprehensive resources that support the complex needs of brain tumor patients and their caregivers. The ABTA has invested over $38 million to advance discoveries and treatments and cultivate the next generation of brain tumor researchers.
aetherAI Co., Ltd.
aetherAI is a leading provider of AI-powered digital pathology solutions, dedicated to enhancing pathology workflow efficiency and accuracy. Our flagship product, aetherSlide, enables seamless digital pathology transformation, while our AI solutions, aetherAI Hema, aetherAI Endo, and aetherAI LN, provide automated diagnostic support for hematology, colorectal polyp detection, and lymph node metastasis detection. We collaborate with top medical institutions in Taiwan, Japan, Germany, and the U.S. to advance AI-assisted precision medicine.
A Cure In Sight
ACIS strives to improve the lives of OM patients and caregivers through support, education, advocacy, and by accelerating research that leads to earlier detection, better treatment, and ultimately, a cure.